[Treatment of arrhythmia in pregnancy].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000628:therapy*; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004341:Drug Evaluation; D004554:Electric Countershock; D005260:Female; D006801:Humans; D007799:Lanatosides / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000628:therapy*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D007799:Lanatosides; C018548:lanatoside C
Leczenie zaburzeń rytmu serca u kobiet ciezarnych.